Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. NVDA
2. PSKY
3. META
4. LGND
5. SPY
6. MONC:IM
7. PTON
8. NYXH
9. LXEO
10. MONRY

Go back to Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®
Aethlon Medical, Inc. (NASDAQ: AEMD) Delayed: 6.85 +0.53 (8.39%)
Previous Close $6.32    52 Week High $9.09 
Open $6.20    52 Week Low $4.02 
Day High $6.98    P/E N/A 
Day Low $6.20    EPS $-0.05 
Volume 218,999